| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer
|
Reck, Martin
|
|
2009
|
63 |
1 |
p. 1-9
9 p.
|
artikel
|
| 2 |
A follow-up report on a new method of segmental resection for small-sized early lung cancer
|
Bando, Toru
|
|
2009
|
63 |
1 |
p. 58-62
5 p.
|
artikel
|
| 3 |
A phase II study of carboplatin and paclitacel with meloxicam
|
Suzuki, Ryujiro
|
|
2009
|
63 |
1 |
p. 72-76
5 p.
|
artikel
|
| 4 |
A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer
|
Grønberg, Bjørn H.
|
|
2009
|
63 |
1 |
p. 88-93
6 p.
|
artikel
|
| 5 |
Association of positive family history with survival of patients with lung cancer
|
Ganti, Apar Kishor
|
|
2009
|
63 |
1 |
p. 136-139
4 p.
|
artikel
|
| 6 |
Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells
|
Wang, Wei
|
|
2009
|
63 |
1 |
p. 23-31
9 p.
|
artikel
|
| 7 |
Contents
|
|
|
2009
|
63 |
1 |
p. vii-viii
nvt p.
|
artikel
|
| 8 |
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients
|
Soo, Ross A.
|
|
2009
|
63 |
1 |
p. 121-127
7 p.
|
artikel
|
| 9 |
Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study
|
Boukovinas, I.
|
|
2009
|
63 |
1 |
p. 77-82
6 p.
|
artikel
|
| 10 |
EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy
|
Tournoy, Kurt G.
|
|
2009
|
63 |
1 |
p. 45-49
5 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2009
|
63 |
1 |
p. v-
1 p.
|
artikel
|
| 12 |
Endobronchial ultrasound for diagnosis of synchronous primary lung cancers
|
Wong, Matthew K.
|
|
2009
|
63 |
1 |
p. 154-157
4 p.
|
artikel
|
| 13 |
Erythema elevatum diutinum as a paraneoplastic syndrome in a patient with pulmonary lymphoepithelioma-like carcinoma
|
Liu, Ta-Chiang
|
|
2009
|
63 |
1 |
p. 151-153
3 p.
|
artikel
|
| 14 |
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes
|
Kuner, Ruprecht
|
|
2009
|
63 |
1 |
p. 32-38
7 p.
|
artikel
|
| 15 |
Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma
|
Watanabe, Fumiaki
|
|
2009
|
63 |
1 |
p. 39-44
6 p.
|
artikel
|
| 16 |
Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer
|
Iranzo, Vega
|
|
2009
|
63 |
1 |
p. 63-67
5 p.
|
artikel
|
| 17 |
Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer
|
Han, Ji-Youn
|
|
2009
|
63 |
1 |
p. 115-120
6 p.
|
artikel
|
| 18 |
Long-term results of lung cancer after heart transplantation: Single center 20-year experience
|
Bruschi, Giuseppe
|
|
2009
|
63 |
1 |
p. 146-150
5 p.
|
artikel
|
| 19 |
Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: Meta-analysis of randomized clinical trials
|
Bria, Emilio
|
|
2009
|
63 |
1 |
p. 50-57
8 p.
|
artikel
|
| 20 |
Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis
|
Rossi, Giulio
|
|
2009
|
63 |
1 |
p. 159-160
2 p.
|
artikel
|
| 21 |
Non-small cell lung cancer and silent brain metastasis
|
Sánchez de Cos, Julio
|
|
2009
|
63 |
1 |
p. 140-145
6 p.
|
artikel
|
| 22 |
Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer
|
Holdenrieder, Stefan
|
|
2009
|
63 |
1 |
p. 128-135
8 p.
|
artikel
|
| 23 |
Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer
|
Ozawa, Yuichi
|
|
2009
|
63 |
1 |
p. 68-71
4 p.
|
artikel
|
| 24 |
Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer
|
Lee, Jin Gu
|
|
2009
|
63 |
1 |
p. 106-110
5 p.
|
artikel
|
| 25 |
Regional differences in treatment and outcome in non-small cell lung cancer: A population-based study (Sweden)
|
Myrdal, Gunnar
|
|
2009
|
63 |
1 |
p. 16-22
7 p.
|
artikel
|
| 26 |
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer
|
Safont, María José
|
|
2009
|
63 |
1 |
p. 83-87
5 p.
|
artikel
|
| 27 |
Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients
|
Yano, Tokujiro
|
|
2009
|
63 |
1 |
p. 111-114
4 p.
|
artikel
|
| 28 |
TA-MUC1 epitope in non-small cell lung cancer
|
Kuemmel, Andreas
|
|
2009
|
63 |
1 |
p. 98-105
8 p.
|
artikel
|
| 29 |
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
|
Stebbing, Justin
|
|
2009
|
63 |
1 |
p. 94-97
4 p.
|
artikel
|
| 30 |
Treatment of non-small cell lung cancer patients with performance status2 (PS2)
|
Boukovinas, Ioannis
|
|
2009
|
63 |
1 |
p. 10-15
6 p.
|
artikel
|
| 31 |
Understanding the effectiveness of intensive follow-up for patients with SCLC
|
Melder, Angela
|
|
2009
|
63 |
1 |
p. 158-
1 p.
|
artikel
|
Tijdschrift beschrijving